Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284141 | 12528414 | 1 | I | 20160512 | 20160627 | 20160705 | 20160705 | EXP | IT-SA-2016SA120094 | AVENTIS | 79.00 | YR | E | M | Y | 0.00000 | 20160705 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284141 | 12528414 | 1 | PS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | Y | U | UNK | 20839 | TABLET | |||||||
| 125284141 | 12528414 | 2 | C | MADOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | 0 | CAPSULE, HARD | |||||||||||
| 125284141 | 12528414 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 60 | MG | TABLET | ||||||||
| 125284141 | 12528414 | 4 | C | PRITOR PLUS | TELMISARTAN | 1 | Oral | STRENGTH: 12.5MG/80MG | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125284141 | 12528414 | 1 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125284141 | 12528414 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125284141 | 12528414 | Anaemia | |
| 125284141 | 12528414 | Melaena | |
| 125284141 | 12528414 | Peptic ulcer | |
| 125284141 | 12528414 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |